A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
119-S-5059119th CongressIntroduced Jul 21, 2026Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor
Sen. Moody, Ashley [R-FL](R-FL)3 cosponsors
Actions (2)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 21, 2026Senate
Introduced in Senate
Jul 21, 2026Library of Congress